0 CommentsYou never know when an acquisition involving the automobile industry in the Midwest in 1998 might affect a drug-development firm in the Philadelphia... Read more
0 CommentsShire P.L.C. will buy SARcode Bioscience Inc., which is developing a treatment for dry eyes, in a deal worth at least $160 million. The pharmaceutical... Read more
0 CommentsShares of AmerisourceBergen Corp. were up 7 percent Tuesday morning after the pharmaceutical wholesaler signed long-term deals to supply Walgreen... Read more
0 CommentsI am no fan of economic-impact studies because, while written by third-party economists, they are usually paid for by organizations who want... Read more
0 CommentsBioClinica Inc., a Bucks County-based provider of clinical trial management services, will be acquired by JLL Partners Inc., a New York private-equity... Read more
0 CommentsOne factoid that didn't make it into my column in Wednesday's newspaper on state subsidies to corporations, which focused on Delaware's $11... Read more
0 CommentsAn update to my column in Tuesday's paper about the mix of messages emerging from several of the region's life-sciences firms: A spokeswoman... Read more
Inquirer business columnist Mike Armstrong and other staff writers take you beyond the business headlines in Philadelphia.